STOCK TITAN

Amedisys Announces First Quarter 2023 Earnings Release and Conference Call Date

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary

Amedisys, Inc. (NASDAQ: AMED) will announce its first quarter results for the period ending March 31, 2023, on May 3, 2023, post-market closure. An investor call will follow on May 4, 2023, at 11:00 a.m. ET, where executives will discuss the results. Investors can join the call by dialing (888) 437-3179 or (862) 298-0702. A replay will be available until June 4, 2023. Amedisys, a leader in home health, hospice, and high-acuity care, focuses on delivering personalized healthcare services. The company operates over 522 care centers across 37 states and serves more than 465,000 patients annually, performing over 11.2 million visits each year.

Positive
  • Increasing patient outreach with over 465,000 patients served annually.
  • Operational presence in 37 states with 522 care centers, indicating strong market reach.
Negative
  • None.

BATON ROUGE, La., April 20, 2023 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED), a leading provider of home health, hospice and high-acuity care, will report results for the first quarter ended March 31, 2023, after the market closes on May 3, 2023. The Company will host an investor conference call to discuss these results at 11:00 a.m. ET on May 4, 2023.

To participate on the conference call, please call a few minutes before 11:00 a.m. ET to either (888) 437-3179 (toll-free) or (862) 298-0702 (toll). A replay of the call will be available through June 4, 2023, by dialing (877) 660-6853 (toll-free) or (201) 612-7415 (toll) and entering access ID 13737736.

To access a live webcast of the Amedisys presentations, please log on through our website at http://investors.amedisys.com.

About Amedisys:

Amedisys, Inc. is a leading healthcare at home Company delivering personalized home health, hospice and high-acuity care services. Amedisys is focused on delivering the care that is best for our patients, whether that is inpatient hospital, palliative, and skilled nursing facility (“SNF”) care in their homes; home-based recovery and rehabilitation after an operation or injury; care focused on empowering them to manage a chronic disease; or hospice care at the end of life. More than 3,000 hospitals and 102,000 physicians nationwide have chosen Amedisys as a partner in post-acute care. Founded in 1982, headquartered in Baton Rouge, LA with an executive office in Nashville, TN, Amedisys is a publicly held company. With approximately 18,000 employees, in 522 care centers in 37 states and the District of Columbia, Amedisys is dedicated to delivering the highest quality of care to the doorsteps of more than 465,000 patients in need every year, performing more than 11.2 million visits annually. For more information about the Company, please visit: www.amedisys.com.

Contact: 
Nick MuscatoKendra Kimmons
Amedisys, Inc.Amedisys, Inc.
Chief Strategy OfficerMedia Relations
615.928.5452225.299.3720
nick.muscato@amedisys.comkendra.kimmons@amedisys.com

FAQ

When will Amedisys report its Q1 2023 earnings?

Amedisys will report its Q1 2023 earnings on May 3, 2023, after the market closes.

What time is the Amedisys investor conference call?

The investor conference call will take place on May 4, 2023, at 11:00 a.m. ET.

How can I participate in the Amedisys earnings call?

To participate, call (888) 437-3179 or (862) 298-0702 a few minutes before the call starts.

Is there a replay available for the Amedisys earnings call?

Yes, a replay will be available until June 4, 2023, by dialing (877) 660-6853 or (201) 612-7415.

How many patients does Amedisys serve annually?

Amedisys serves over 465,000 patients every year.

Amedisys Inc

NASDAQ:AMED

AMED Rankings

AMED Latest News

AMED Stock Data

2.75B
32.14M
2.38%
90.41%
6.66%
Medical Care Facilities
Services-home Health Care Services
Link
United States of America
BATON ROUGE